Strike halves Saturn deliveries
A trucking strike has cut deliveries of Saturn automobiles in half, the General Motors Corp. subsidiary said yesterday.
Only two tractor-trailer rigs loaded with Saturns have arrived at dealerships since 82 Teamsters members walked off the job Saturday at Transportation Unlimited Inc., a company that supplies truck drivers.
Saturn produces about 1,100 cars a day, and dealers now have a 55-day supply, Saturn spokesman Bill Betts said.
Air strike date may be earlier
American Airlines' flight attendants union said yesterday that they plan to meet next week to decide on possibly moving up its strike date.
The Association of Professional Flight Attendants had previously said if a contract was not agreed upon, the union would strike on or before Nov. 22, just ahead of the busy Thanksgiving holiday.
But now some of the flight attendants for American Airlines, a unit of AMR Corp., are saying they want to make the strike date earlier.
Volvo sticks with Renault pact
Sweden's AB Volvo, which plans to merge its automotive operations with France's Renault, said it won't renegotiate the agreement even though criticism yesterday forced it to postpone a shareholders' vote on the matter.
"A new agreement can't be contemplated," Volvo chairman Pehr Gyllenhammar said yesterday.
The Volvo board decided late Monday night to give shareholders until Dec. 7 to consider the merger. Shareholders and other opponents in Sweden have questioned financial aspects of the deal and have expressed alarm that Sweden would sell its largest industrial corporation to France.
McDonald's outlets in gas stations
McDonald's Corp. said yesterday that it has opened five limited-menu outlets at gas stations.
The kiosks and counters, located at stations in Arkansas, Florida, Indiana and Massachusetts, are the latest test of a marketing philosophy that has put McDonald's in hospitals, Wal-Mart stores and airports, and aboard airplanes.
The company said it was too early in the testing to say whether the concept would be expanded.
Merck suspends trials for drug
Merck & Co. suspended trials of an anti-schizophrenia drug yesterday after learning that eight patients in Europe developed bone marrow problems while using it.
The drug Roxiam is under review by the federal Food and Drug Administration and is being tested by more than 100 patients at 30 centers nationwide, Merck spokesman Roy Walker said.
No direct links have been made between the drug and the illnesses.